Brian S. Tyler

Brian S. Tyler has built a distinguished career in the healthcare and pharmaceuticals industry, showcasing a deep understanding of business transformation and global operations. His leadership journey includes overseeing major strategic initiatives and steering diverse business units at McKesson Corporation, enabling him to develop a comprehensive perspective on corporate growth and operational excellence. " " "

His progression through various executive roles—ranging from President and Chief Operating Officer in North America to leadership positions in Europe—highlights his agility in navigating complex business landscapes and his commitment to driving sustainable business improvements. " " " "

Beyond his principal role at McKesson, he contributes to the industry by serving on the boards of prominent organizations such as Republic Services, Inc. and the International Federation of Pharmaceutical Wholesalers. His active involvement in philanthropic endeavors, including the American Cancer Society’s CEOs Against Cancer group, underscores a long-term commitment to community and industry advancement. " "

Annual Cash Incentive (MIP)

• Eligible Earnings: $1,490,000 "
• MIP Target (% of Salary): 185% "
• MIP Target Award: $2,756,500 "
• MIP Payout Earned: 114% of target, resulting in $3,142,410 "
• Vesting: No vesting; this is an annual cash incentive paid after fiscal year-end

Performance Stock Units (PSUs)

• PSU Payout: 200% of target awards "
• Grant Date: May 23, 2023 "
• Grant Date Fair Value: $8,100,237 "
• Grant Date Stock Price: $393.14 per unit "
• PSU Target Awards: 19,084 units "
• Vesting Schedule: Three-year performance period; vests in May 2026 "

Value of Stock Vesting upon Involuntary Termination in Connection with a Change in Control